Perceptive Advisors LLC

Investment Portfolio & 13F Holdings Analysis

About
CIK: 0001224962
Type: FundHoldings: 86Value: $2.7BLatest: 2025Q1

PERCEPTIVE ADVISORS LLC is an institutional investment manager that filed its latest Form 13F for 2025Q1, reporting 86 holdings worth $2.7 billion. Form 13F filings provide transparency into the equity holdings of institutional investment managers with over $100 million in assets under management. This page displays the most recent portfolio holdings, allowing investors to track position changes, new investments, and portfolio composition.

Filing Details

13F-HR2025-03-31
Report Date
2025-03-31
Filing Date
2025-05-15
Total Holdings
86
Total Value
2694161578
Accession Number
0001012975-25-000242
Form Type
13F-HR
Manager Name
Perceptive-Advisors
Data Enrichment
87% identified
75 identified11 unidentified

Holdings

86 positions • $2.7B total value
Manager:
Search and click to pin securities to the top
Page 1 of 5
Verona Pharma plc
Shares:6.6M
Value:$416.7M
% of Portfolio:15.5% ($416.7M/$2.7B)
Arcellx, Inc.
Shares:2.9M
Value:$192.0M
% of Portfolio:7.1% ($192.0M/$2.7B)
AMICUS THERAPEUTICS, INC.
Shares:21.5M
Value:$175.2M
% of Portfolio:6.5% ($175.2M/$2.7B)
RHYTHM PHARMACEUTICALS, INC.
Shares:2.5M
Value:$135.0M
% of Portfolio:5.0% ($135.0M/$2.7B)
Nuvalent, Inc.
Shares:1.6M
Value:$115.9M
% of Portfolio:4.3% ($115.9M/$2.7B)
SOLENO THERAPEUTICS INC
Shares:1.5M
Value:$107.6M
% of Portfolio:4.0% ($107.6M/$2.7B)
46116X101
Shares:786.4K
Value:$103.7M
% of Portfolio:3.9% ($103.7M/$2.7B)
MeiraGTx Holdings plc
Shares:12.6M
Value:$85.3M
% of Portfolio:3.2% ($85.3M/$2.7B)
ARTIVION, INC.
Shares:2.8M
Value:$68.7M
% of Portfolio:2.5% ($68.7M/$2.7B)
Aldeyra Therapeutics, Inc.
Shares:9.3M
Value:$53.3M
% of Portfolio:2.0% ($53.3M/$2.7B)
Protagonist Therapeutics, Inc
Shares:1.1M
Value:$52.8M
% of Portfolio:2.0% ($52.8M/$2.7B)
Evolus, Inc.
Shares:4.1M
Value:$49.7M
% of Portfolio:1.8% ($49.7M/$2.7B)
Immunovant, Inc.
Shares:2.8M
Value:$48.6M
% of Portfolio:1.8% ($48.6M/$2.7B)
Solid Biosciences Inc.
Shares:11.9M
Value:$44.1M
% of Portfolio:1.6% ($44.1M/$2.7B)
Centessa Pharmaceuticals plc
Shares:3.0M
Value:$43.7M
% of Portfolio:1.6% ($43.7M/$2.7B)
IOVANCE BIOTHERAPEUTICS, INC.
Shares:12.7M
Value:$42.3M
% of Portfolio:1.6% ($42.3M/$2.7B)
Immatics N.V.
Shares:9.4M
Value:$42.3M
% of Portfolio:1.6% ($42.3M/$2.7B)
Apogee Therapeutics, Inc.
Shares:1.1M
Value:$41.9M
% of Portfolio:1.6% ($41.9M/$2.7B)
Axsome Therapeutics, Inc.
Shares:355.1K
Value:$41.4M
% of Portfolio:1.5% ($41.4M/$2.7B)
INSMED Inc
Shares:509.3K
Value:$38.9M
% of Portfolio:1.4% ($38.9M/$2.7B)